Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Applied Genetic is a biotechnology business based in the US. Applied Genetic shares (AGTC) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Genetic employs 83 staff and has a trailing 12-month revenue of around $500,000.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $0.29 |
|---|---|
| 52-week range | $0.28 - $3.35 |
| 50-day moving average | $0.40 |
| 200-day moving average | $1.14 |
| Wall St. target price | $10.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.46 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.285 from 2022-09-26
| 1 week (2022-09-21) | -13.64% |
|---|---|
| 1 month (2022-08-26) | -32.99% |
| 3 months (2022-06-28) | -61.78% |
| 6 months (2022-03-25) | -76.83% |
| 1 year (2021-09-28) | -90.87% |
|---|---|
| 2 years (2020-09-28) | -94.20% |
| 3 years (2019-09-27) | 3.99 |
| 5 years (2017-09-27) | 3.7 |
| Revenue TTM | $500,000 |
|---|---|
| Gross profit TTM | $-22,583,000 |
| Return on assets TTM | -35.87% |
| Return on equity TTM | -87.06% |
| Profit margin | 0% |
| Book value | $0.93 |
| Market capitalisation | $19.5 million |
TTM: trailing 12 months
We're not expecting Applied Genetic to pay a dividend over the next 12 months.
Over the last 12 months, Applied Genetic's shares have ranged in value from as little as $0.28 up to $3.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Genetic's is 1.2601. This would suggest that Applied Genetic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida. .
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.